Measuring impact of a reliable, cost-effective supply
Today, there are virtually no stockouts of anti-retroviral drugs (ARVs) in PEPFAR-supported programs, and SCMS provides enough ARVs to support over half the 3.2 million people on treatment through PEPFAR.
While many non-PEPFAR-supported programs struggle with stockouts and unreliable supply, SCMS’s on-time delivery averaged 80 percent in 2010.
SCMS has trained staff in multiple countries to buy appropriate laboratory commodities in the local market, further driving down the cost of procurement, reducing delivery times and transferring valuable skills to the local workforce. SCMS has also helped transform public health supply chains in many countries, strengthening warehousing, distribution, logistics management, quality assurance and other key supply chain disciplines.
Using strategic stock in its innovative regional distribution centers, and leveraging relationships with suppliers, SCMS has become an obvious choice for emergency suppliers within US Government and other programs. Access examples of our impact.
.
SCMS, by any measure, is a sound investment by PEPFAR and the US Government.